Neurotech Reports Announces 2018 Bioelectronic Medicine Forum
December 2017 issue
Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced the launch of a new conference related to bioelectronic medicine. The 2018 Bioelectronic Medicine Forum will take place in New York City on March 22, 2018. The inaugural one-day event will take place at the Millennium Broadway Hotel & Conference Center, one day prior to the BioCentury Future Leaders Conference at the same venue.
Co-sponsors of the first annual Bioelectronic Medicine Forum are The Feinstein Institute for Medical Research and Action Potential Venture Capital. The Feinstein institute has played a leadership role in the emerging field of bioelectronic medicine, funding key research programs and helping launch several promising commercial ventures. Action Potential Venture Capital, backed by GlaxoSmithKline, has led investment in several key startups in the bioelectronic medicine industry. APVC Partner Imran Eba will serve as co-chair and conference director.
Neurotech Reports editors James Cavuoto, Jennifer French, and Jeremy Koff are currently recruiting panelists and presenters for the March 22 event. Key topics will include promising indications, alliances with bio/pharm firms, regulatory and reimbursement issues, and pricing/commercialization issues.
Gene Civillico, program manager for the National Institutes of Health's SPARC program, and Eric Van Gieson, who oversees DARPA's ElectRx and other programs, will deliver opening keynote addresses.
There will also be opportunities for invited and sponsored presentations from key startup firms in the bioelectronic medicine space. Entrepreneur presenters will have 15 minutes to describe their technology, market opportunity, and management team to potential investors.
For more information on presenting or sponsoring the 2018 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259.